Latest News about financial results
Recent news which mentions financial results
Cannabis Health-Tech Reports YoY Drop In Q3 Revenue As It Moves To Diversify Wellness Business
October 30, 2023
Tickers
LFSWF
From Benzinga
Small Pharma's Q2 2024 Financial Highlights Ahead Of Cybin Merger For Global DMT Business
October 20, 2023
From Benzinga
Nevada Cannabis Co. Reports YoY Decrease In Q1 Revenue & Gross Profit, 154% Increase In Cash Flow
October 13, 2023
Tickers
CLSH
From Benzinga
Revenue Drops, Loss Grows YoY For This Cannabis Operator In Q1, Plans Expansion In New Jersey
September 29, 2023
Tickers
TPPRF
From Benzinga
Vancouver Cannabis Producer Reports 17th Consecutive Quarter Of Positive Cash Flow Amid Industry Headwinds
September 21, 2023
Tickers
CXXIF
From Benzinga
Braxia Scientific Faces Challenges In Accessing Public Market Capital, Reports Q1 Loss
August 31, 2023
Tickers
BRAXF
From Benzinga
From Benzinga
Simply Better Brands Reports Adjusted EBITDA Loss In Q2, CEO Confident In Revenue & Profit Growth For 2023
August 30, 2023
From Benzinga
From Benzinga
From Benzinga
RIV Capital Reports YoY Revenue Growth In Q2, Plans To Establish Dominant Role In New York Wholesale Market
August 29, 2023
Tickers
CNPOF
From Benzinga
Irwin Naturals Revenue Sluggish In Q2, Net Loss Grows YOY
August 28, 2023
Tickers
IWINF
From Benzinga
This Canadian Co. Said Farewell To Cannabis, Stock Surges On Heels Of Q1 Earnings Report
August 18, 2023
Tickers
NEPT
From Benzinga
Canadian Cannabis Producer Reports YoY Revenue Spike In Q2, Earnings Show Stable Growth As Demand Grows
August 17, 2023
Tickers
DBCCF
From Benzinga
$21.8M Revenue For NASDAQ-Listed Psychedelics Ancillary Company Societal CDMO's Q2 2023
August 16, 2023
Tickers
SCTL
From Benzinga
Cresco Labs Reports Slight Sequential Improvement In Q2, YoY Drop In Revenue And Gross Profit As Net Loss Grows
August 16, 2023
From Benzinga
Filament Health Shares Q1 2023 Financials, Material Uncertainties Upon Securing Additional Financing
August 15, 2023
From Benzinga
Mydecine Releases Q2 2023: Developer Of Smoke Cessation Psilocybin Prodrugs & MDMA Analogs
August 15, 2023
Tickers
MYCOF
From Benzinga
Canadian Cannabis Producer Reports Revenue Spike And Improved Margins In Q2, But What About Net Loss?
August 15, 2023
Tickers
AVCNF
From Benzinga
Cybin's Q1 2023 Financials, Deuterated Psychedelics Moving 'Steadily' Through The Clinic
August 14, 2023
Tickers
CYBN
From Benzinga
Enveric's Q2 2023 Financials Show Immediate Need For Budget-Slimming Toward A Clinical-Staged 2024
August 14, 2023
Tickers
ENVB
From Benzinga
Cannabis Real Estate Firm's Q2 Earnings Results Signal Steady Growth, Here's What You Need To Know
August 14, 2023
Tickers
ZDPY
From Benzinga
IM Cannabis Stock Drops On Q2 Earnings, CEO Touts Strategic Decisions That Led To 'Sustainable Profitability'
August 14, 2023
Tickers
IMCC
From Benzinga
Columbia Care: Q2 Report Reveals Profits In East Coast Market But This Was Before Failed Sean Diddy Mega Merger
August 14, 2023
From Benzinga
Atai's Q2 2023 Plus Clinical Data On Ibogaine-Opioid Study, Pipeline's Psilocybin, DMT, Ketamine & MDMA
August 10, 2023
From Benzinga
MindMed's Q2 2023: One Of Biggest Players In The Space Sustains Faith In LSD's Multiple Path Ahead
August 07, 2023
Tickers
MNMD
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.